Cardiac health for astronauts: Coronary calcification scores and CRP as criteria for selection and retention

Aviation Space and Environmental Medicine

Volumn 77, Issue 4, 2006, Pages 377-387

  Hamilton, Douglas R ^a,c   Murray, Jocelyn D ^a   Ball, Chad G ^b  

^a WYLE LABORATORIES   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c NASA HEADQUARTERS   (United States)

Author keywords

Astronaut; c reactive protein; Cholesterol; Coronary artery disease; Electron beam computed tomography; International Space Station; Mars; Moon; Risk factors; Space exploration; Spaceflight

Indexed keywords

C REACTIVE PROTEIN; CALCIUM;

ALGORITHM; ARTERY CALCIFICATION; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORONARY ARTERY DISEASE; COSMONAUT; DIAGNOSTIC PROCEDURE; ELECTRON BEAM TOMOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; PROTEIN BLOOD LEVEL; REVIEW; SCREENING; SPACE FLIGHT;

AEROSPACE MEDICINE; ALGORITHMS; ASTRONAUTS; C-REACTIVE PROTEIN; CALCINOSIS; CORONARY ARTERIOSCLEROSIS; HUMANS; MASS SCREENING; PERSONNEL SELECTION; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645722033     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Achenbach S, Moshage W, Ropers D, et al. Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary-artery stenoses and occlusions. N Engl J Med 1998; 339:1964-71.
2. Achenbach S, Ropers D, Mohlenkamp S, et al. Variability of repeated coronary artery calcium measurements by electron beam tomography. Am J Cardiol 2001; 87:210-3, A8.
3. Agatston AS, Janowitz WR. Ultrafast computed tomography in coronary screening. Circulation 1994; 89:1908-9.
4. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827-32.
5. Albert CM, Ma J, Rifai N, et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002; 105:2595-9.
6. Altman R. Risk factors in coronary atherosclerosis athero-inflammation: the meeting point. Thromb J 2003; 1:4.
7. Arad Y, Goodman KJ, Roth M, et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study. J Am Coll Cardiol 2005; 46:158-65.
8. Arad Y, Spadaro LA, Goodman K, et al. Predictive value of electron beam computed tomography of the coronary arteries: 19-month follow-up of 1173 asymptomatic subjects. Circulation 1996; 93:1951-3.
9. Arad Y, Spadaro LA, Goodman K, et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 2000; 36:1253-60.
10. Badak O, Schoenhagen P, Tsunoda T, et al. Characteristics of atherosclerotic plaque distribution in coronary artery bifurcations: an intravascular ultrasound analysis. Coron Artery Dis 2003; 14:309-16.
11. Becker CR, Knez A, Jakobs TF, et al. Detection and quantification of coronary artery calcification with electron-beam and conventional CT. Eur Radiol 1999; 9:620-4.
12. Bielak LF, Kaufmann RB, Moll PP, et al. Small lesions in the heart identified at electron beam CT: calcification or noise? Radiology 1994; 192:631-6.
13. Bielak LF, Sheedy PF 2nd, Peyser PA. Coronary artery calcification measured at electron-beam CT: agreement in dual scan runs and change over time. Radiology 2001; 218:224-9.
14. Blake GJ, Ridker PM. C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events. Arterioscler Thromb Vase Biol 2002; 22:1512-3.
15. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337:1360-9.
16. Breen JF, Sheedy PF 2nd, Schwartz RS, et al. Coronary artery calcification detected with ultrafast CT as an indication of coronary artery disease. Radiology 1992; 185:435-9.
17. Budoff MJ, Lane KL, Bakhsheshi H, et al. Rates of progression of coronary calcium by electron beam tomography. Am J Cardiol 2000; 86:8-11.
18. Chamberlain D. Second European Workshop in Aviation Cardiology. Attributable and absolute (polymorphic) risk in aviation certification: developing the 1% rule. Eur Heart J 1999; 1(suppl. D):D19-24.
19. Cheng YJ, Church TS, Kimball TE, et al. Comparison of coronary artery calcium detected by electron beam tomography in patients with to those without symptomatic coronary heart disease. Am J Cardiol 2003; 92:498-503.
20. de Feyter PJ, Nieman K. New coronary imaging techniques: what to expect? Heart 2002; 87:195-7.
21. Dehn MM, Bruce RA. Longitudinal variations in maximal oxygen uptake with age and activity. J Appl Physiol 1972; 33:805-12.
22. Detrano RC, Anderson M, Nelson J, et al. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility-MESA study. Radiology 2005; 236:477-84.
23. Edwards CJ, Spector TD. Statins as modulators of bone formation. Arthritis Res 2002; 4:151-3.
24. Elgin EE, O'Malley PG, Feuerstein I, et al. Frequency and severity of "incidentalomas" encountered during electron beam computed tomography for coronary calcium in middle-aged army personnel. Am J Cardiol 2002; 90:543-5.
25. Enos WF, Holmes RH, Beyer J. Coronary artery disease among United States soldiers killed in action in Korea. JAMA 1953; 152:1090-3.
26. Fitzsimmons P, Palm-Leis A, Thompson W, et al. Comparison of noninvasive cardiac testing in 759 military aviators; angiographic correlation and clinical follow-up [Abstract]. Aviat Space Environ Med 2001; 72:229-30.
27. Fitzsimmons P, Siauson J, Kruyer W, et al. Risk equation to predict significant coronary artery disease and cardiac events in asymmptomatic male aviators with abnormal noninvasive tests. Proceedings of the Aerospace Medical Association's 72nd Annual Scientific Meeting; 6-10 May 2001; Reno, Nevada. Alexandria, VA: Aerospace Medical Association, 2001.
28. Folarin VA, Fitzsimmons PJ, Kruyer WB. Spectrum of Holter findings in asymptomatic male military aircrew without structural heart disease. Proceedings of the Aerospace Medical Association's 71st Annual Scientific Meeting; 14-18 May 2000; Houston, TX. Alexandria, VA: Aerospace Medical Association; 2000.
29. Friedrich GJ, Hausmann D, Fitzgerald PJ, et al. Prognostic value of coronary calcification II. J Am Coll Cardiol 1996; 28:284; author reply 284-5.
30. Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004; 291:210-5.
31. Guerci AD, Spadaro LA, Popma JJ, et al. Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults. Am J Cardiol 1997; 79:128-33.
32. Hamilton DR. Cardiovascular issues for space travel. In: Barratt ML, Pool SL, eds. Principles of clinical medicine for spaceflight. New York: Springer-Verlag; (In press).
33. Hamilton DR, Murray JD, Ball CG, et al. Cardiac health for astronauts: current selection standards and their limitations. Aviat Space Environ Med 2005; 76:615-26.
34. Hill JA, Goldin JG, Gjertson D, et al. Progression of coronary artery calcification in patients taking alendronate for osteoporosis. Acad Radiol 2002; 9:1148-52.
35. Hunold P, Vogt FM, Schmermund A, et al. Radiation exposure during cardiac CT: effective doses at multi-detector row CT and electron-beam CT. Radiology 2003; 226:145-52.
36. Hunt ME, O'Malley PG, Vernalis MN, et al. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 2001; 141:206-10.
37. Janowitz WR, Agatston AS, Kaplan G, et al. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am J Cardiol 1993; 72:247-54.
38. LaMonte MJ, FitzGerald SJ, Church TS, et al. Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women. Am J Epidemiol 2005; 162:421-9.
39. Lima JA, Desai MY, Steen H, et al. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 2004; 110:2336-41.
40. Loecker TH, Schwartz RS, Cotta CW, et al. Fluoroscopic coronary artery calcification and associated coronary disease in asymptomatic young men. J Am Coll Cardiol 1991; 19:1167-72.
41. McNamara JJ, Molot MA, Stremple JF, et al. Coronary artery disease in combat casualties in Vietnam. JAMA 1972; 216:1185-7.
42. Nasir K, Raggi P, Rumberger JA, et al. Coronary artery calcium volume scores on electron beam tomography in 12,936 asymptomatic adults. Am J Cardiol 2004; 93:1146-9.
43. Nissen SE. Who is at risk for atherosclerotic disease? Lessons from intravascular ultrasound. Am J Med 2002; 112(Suppl. 8A):27S-33S.
44. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 2005; 352:29-38.
45. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001; 103:604-16.
46. O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation 2000; 102:126-40.
47. Park R, Detrano R, Xiang M, et al. Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 2002; 106:2073-7.
48. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102:2165-8.
49. Pasternak RC, Smith SC Jr, Bairey-Merz CN, et al. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Stroke 2002; 33:2337-41.
50. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107:499-511.
51. Pettyjohn FS, McMeekin RR. Coronary artery disease and preventive cardiology in aviation medicine. Aviat Space Environ Med 1975; 46:1299-304.
52. Pletcher MJ, Tice JA, Pignone M, et al. What does my patient's coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk. BMC Med 2004; 2:31.
53. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation 2000; 101:850-5.
54. Raggi P, Cooil B, Callister TQ. Use of electron beam tomography data to develop models for prediction of hard coronary events. Am Heart J 2001; 141:375-82.
55. Redberg RF, Rifai N, Gee L, et al. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol 2000; 36:39-43.
56. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107:363-9.
57. Ridker PM. Connecting the role of C-reactive protein and statins in cardiovascular disease. Clin Cardiol 2003; 26(4, Suppl. 3): III39-44.
58. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 2003; 92(4B):17K-22K.
59. Ridker PM. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. Circulation 2003; 108:2292-7.
60. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 2003; 107:391-7.
61. Ridker PM, Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 2004; 109:1955-9.
62. Ridker PM, Koenig W, Fuster V. C-reactive protein and coronary heart disease. N Engl J Med 2004; 351:295-8; author reply 295-8.
63. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344:1959-65.
64. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557-65.
65. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-9.
66. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-26.
67. Rumberger JA, Simons DB, Fitzpatrick LA, et al. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995; 92:2157-62.
68. Schoenhagen P, Halliburton SS, Stillman AE, et al. Noninvasive imaging of coronary arteries: current and future role of multidetector row CT. Radiology 2004; 232:7-17.
69. Secci A, Wong N, Tang W, et al. Electron beam computed tomographic coronary calcium as a predictor of coronary events: comparison of two protocols. Circulation 1997; 96:1122-9.
70. Shaw LJ, O'Rourke RA. The challenge of improving risk assessment in asymptomatic individuals: the additive prognostic value of electron beam tomography? J Am Coll Cardiol 2000; 36:1261-4.
71. Smalley BW, Loecker TH, Collins TR, et al. Positive predictive value of cardiac fluoroscopy in asymptomatic U.S. army aviators. Aviat Space Environ Med 2000; 71:1197-201.
72. Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2001; 38:1581-3.
73. Sutton-Tyrrell K, Kuller LH, Edmundowicz D, et al. Usefulness of electron beam tomography to detect progression of coronary and aortic calcium in middle-aged women. Am J Cardiol 2001; 87:560-4.
74. Taneja N, Wiegmann DA. Prevalence of cardiovascular abnormalities in pilots involved in fatal general aviation airplane accidents. Aviat Space Environ Med 2002; 73:1025-30.
75. Taylor AJ, Bindeman J, Feuerstein I, et al. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) Project. J Am Coll Cardiol 2005; 46:807-14.
76. Teng W, Wong ND, Abrahamson D, et al. Relation of electron beam computed tomography screening for coronary calcium to cardiovascular risk and disease: a review. Coron Artery Dis 1996; 7:383-9.
77. Thompson PD, Balady GJ, Chaitman BR, et al. Task Force 6: coronary artery disease. J Am Coll Cardiol 2005; 45:1348-53.
78. Wang PS, Solomon DH, Mogun H, et al. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 2000; 283:3211-6.
79. Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. Circulation 1996; 94:1175-92.
80. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109(21, Suppl. 1):II2-10.
81. Wong ND, Hsu JC, Detrano RC, et al. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 2000; 86:495-8.
82. Zarr S, Gee M, Fitzsimmons P, et al. Angiographic and clinical follow-up of military aviators with minimal coronary artery disease and serial coronary angiography [Abstract]. Aviat Space Environ Med 2001; 72:230.
83. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98:2334-51.